Praxis Precision Medicines, Inc. (PRAX)
250.06
-3.18
(-1.26%)
USD |
NASDAQ |
Jun 09, 15:53
Praxis Precision Medicines SG&A Expense (Quarterly) : 27.87M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 15.23M |
| ADMA Biologics, Inc. | 27.80M |
| Palisade Bio, Inc. | 4.351M |
| Nuvalent, Inc. | 35.80M |
| Heron Therapeutics, Inc. | 26.45M |